APA

Shimohata H., Yamashita M., Ohgi K., Maruyama H., Takayasu M., Hirayama K. & Kobayashi M. (20210831). Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy. : CEN case reports.

Chicago

Shimohata Homare, Yamashita Marina, Ohgi Kentaro, Maruyama Hiroshi, Takayasu Mamiko, Hirayama Kouichi and Kobayashi Masaki. 20210831. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy. : CEN case reports.

Harvard

Shimohata H., Yamashita M., Ohgi K., Maruyama H., Takayasu M., Hirayama K. and Kobayashi M. (20210831). Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy. : CEN case reports.

MLA

Shimohata Homare, Yamashita Marina, Ohgi Kentaro, Maruyama Hiroshi, Takayasu Mamiko, Hirayama Kouichi and Kobayashi Masaki. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy. : CEN case reports. 20210831.